No detectable infectious agents in Langerhans cell histiocytosis with lung involvement
Year: 2026
Type: article
Abstract: Extract Langerhans cell histiocytosis (LCH) is a rare neoplastic disease of unknown aetiology driven by various somatic mutations in the mitogen-activated protein kinase (MAPK) pathway [1]. LCH is highly heterogeneous and may affect virtually any organ [2]. Lung involvement is frequently observed in adult LCH patients, almost exclusively in young smokers of both sexes [3].
Source: ERJ Open Research
Institutions: Inserm, Université Paris Cité, Assistance Publique – Hôpitaux de Paris, Hôpital Saint-Louis, Institut de recherche Saint-Louis, Hôpital Bichat-Claude-Bernard, Infection, Anti-microbiens, Modélisation, Evolution, HIPI - Immunologie humaine, physiopathologie et immunithérapie, Centre National de la Recherche Scientifique, Institut Cochin
Language: English
Subfield: Physiology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $808
OpenAlex ID: W7154589339
